• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

掌腱膜挛缩症的遗传度:家族聚集性及其临床意义。

The heritability of Dupuytren's disease: familial aggregation and its clinical significance.

作者信息

Hindocha Sandip, John Sally, Stanley John K, Watson Stewart J, Bayat Ardeshir

机构信息

Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, United Kingdom.

出版信息

J Hand Surg Am. 2006 Feb;31(2):204-10. doi: 10.1016/j.jhsa.2005.09.018.

DOI:10.1016/j.jhsa.2005.09.018
PMID:16473680
Abstract

PURPOSE

Dupuytren's disease (DD) is a benign, fibroproliferative disease affecting the hands. The familial occurrence of DD and its presence in identical twins suggests a genetic basis for the condition. Our aims in this study were (1) to provide evidence for familial aggregation of DD by estimating the sibling recurrence-risk ratio and (2) to link previously associated environmental risk factors with family history of DD.

METHODS

Patients diagnosed with DD between the ages of 58 and 81 years (N = 92) were interviewed to assess potential risks and the severity of their conditions. A clinical history and examination were performed and we attempted to interview every family member either in person or through a postal questionnaire.

RESULTS

The sibling recurrence-risk ratio (lambda(s)) equaled 2.9 and ranged from 2.6 to 3.3 based on the 95% confidence intervals for the population prevalence. This suggests a high genetic basis for the causation of DD. A lower age of onset and greater severity of DD were associated significantly with a positive family history of DD. Other factors showed no statistical significance with familial aggregation of DD.

CONCLUSIONS

The familial clustering observed in DD likely is due to genetic influence rather than shared environment, as shown by the lack of association with exposure to environmental risk factors and family history. Understanding the genetic basis of DD is important for developing novel diagnostic, preventative, and therapeutic regimens in the future.

TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic, Level II.

摘要

目的

掌腱膜挛缩症(DD)是一种影响手部的良性纤维增生性疾病。DD的家族性发病及其在同卵双胞胎中的出现提示该疾病存在遗传基础。本研究的目的是:(1)通过估计同胞复发风险率为DD的家族聚集性提供证据;(2)将先前相关的环境风险因素与DD家族史联系起来。

方法

对年龄在58至81岁之间被诊断为DD的患者(N = 92)进行访谈,以评估潜在风险及其病情严重程度。进行了临床病史和检查,我们试图亲自或通过邮寄问卷对每位家庭成员进行访谈。

结果

同胞复发风险率(λs)等于2.9,基于人群患病率的95%置信区间,范围为2.6至3.3。这表明DD的病因有很高的遗传基础。DD发病年龄较低和病情较重与DD家族史呈显著正相关。其他因素与DD的家族聚集性无统计学意义。

结论

DD中观察到的家族聚集可能是由于遗传影响而非共同环境,这表现为与环境风险因素暴露和家族史缺乏关联。了解DD的遗传基础对于未来开发新的诊断、预防和治疗方案很重要。

研究类型/证据水平:预后性研究,二级证据。

相似文献

1
The heritability of Dupuytren's disease: familial aggregation and its clinical significance.掌腱膜挛缩症的遗传度:家族聚集性及其临床意义。
J Hand Surg Am. 2006 Feb;31(2):204-10. doi: 10.1016/j.jhsa.2005.09.018.
2
Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.再探杜普伊特伦氏素质:疾病复发风险的预后指标评估
J Hand Surg Am. 2006 Dec;31(10):1626-34. doi: 10.1016/j.jhsa.2006.09.006.
3
Sibling recurrence risk in Dupuytren's disease.Dupuytren挛缩症的同胞复发风险。
J Hand Surg Eur Vol. 2013 May;38(4):424-9. doi: 10.1177/1753193412453359. Epub 2012 Jul 11.
4
Lack of association of iron metabolism and Dupuytren's disease.
J Eur Acad Dermatol Venereol. 2008 Apr;22(4):476-80. doi: 10.1111/j.1468-3083.2007.02506.x. Epub 2008 Jan 10.
5
Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.掌腱膜挛缩症的遗传易感性:一种新型转化生长因子β(2)多态性与掌腱膜挛缩症无关联
J Hand Surg Br. 2002 Feb;27(1):47-9. doi: 10.1054/jhsb.2001.0689.
6
Dupuytren's disease: personal factors and occupational exposure.掌腱膜挛缩症:个人因素与职业暴露
Am J Ind Med. 2008 Jan;51(1):9-15. doi: 10.1002/ajim.20542.
7
A survey of clinical manifestations and risk factors in women with Dupuytren's disease.掌腱膜挛缩症女性患者的临床表现及危险因素调查。
Acta Orthop Belg. 2008 Aug;74(4):456-60.
8
The importance of genetic susceptibility in Dupuytren's disease.遗传易感性在掌腱膜挛缩症中的重要性。
Clin Genet. 2015 May;87(5):483-7. doi: 10.1111/cge.12410. Epub 2014 May 15.
9
Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden.基于瑞典住院情况的双胞胎及其他兄弟姐妹患哮喘的家族风险。
Clin Exp Allergy. 2007 Sep;37(9):1320-5. doi: 10.1111/j.1365-2222.2007.02737.x.
10
Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease.金属蛋白酶基因表达与掌腱膜挛缩症的临床结果相关。
J Hand Surg Am. 2008 Sep;33(7):1160-7. doi: 10.1016/j.jhsa.2008.04.002.

引用本文的文献

1
Dupuytren's Disease Percutaneous Needle Aponeurotomy: Does Grip Strength Improve Post Procedure?掌腱膜挛缩症的经皮针状腱膜切开术:术后握力会改善吗?
J Clin Med. 2025 Jun 12;14(12):4171. doi: 10.3390/jcm14124171.
2
Molecular genetics of Dupuytren's contracture.掌腱膜挛缩症的分子遗传学
EFORT Open Rev. 2024 Aug 1;9(8):723-732. doi: 10.1530/EOR-23-0056.
3
The Italian version of the Unité Rhumatologique des Affections de la Main (URAM) for Dupuytren's disease: The URAM-I(10).意大利版手部风湿性疾病统一评估量表(URAM)用于杜普伊特伦挛缩症:URAM-I(10)
Hand Ther. 2021 Sep;26(3):91-101. doi: 10.1177/17589983211034532. Epub 2021 Jul 27.
4
Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.掌腱膜挛缩症由 TGF-β1 释放和降解不足介导。
Int J Mol Sci. 2023 Oct 11;24(20):15097. doi: 10.3390/ijms242015097.
5
EPIDEMIOLOGICAL ASPECTS OF DUPUYTREN'S DISEASE IN BRAZIL.巴西掌腱膜挛缩症的流行病学特征
Acta Ortop Bras. 2022 Jul 6;30(spe1):e244900. doi: 10.1590/1413-785220223001e244900. eCollection 2022.
6
Risk Factors for Dupuytren's Contracture: A Case-Control Study.危险因素:掌腱膜挛缩症的病例对照研究。
Comput Intell Neurosci. 2022 Apr 28;2022:3574037. doi: 10.1155/2022/3574037. eCollection 2022.
7
Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.纤维增殖性疾病与糖尿病:了解 Peyronie 病、掌腱膜挛缩症和糖尿病之间的病理生理关系。
Endocrinol Diabetes Metab. 2020 Oct 31;4(2):e00195. doi: 10.1002/edm2.195. eCollection 2021 Apr.
8
Dynamic Manugraphy as a Promising Tool to Assess the Outcome of Limited Aponeurectomy in Patients With Dupuytren's Contracture.动态手法记录作为评估Dupuytren挛缩患者有限腱膜切除术疗效的一种有前景的工具。
Front Med (Lausanne). 2021 Jan 12;7:604891. doi: 10.3389/fmed.2020.604891. eCollection 2020.
9
Dupuytren's disease: where do we stand?掌腱膜挛缩症:我们目前的进展如何?
EFORT Open Rev. 2019 Feb 20;4(2):63-69. doi: 10.1302/2058-5241.4.180021. eCollection 2019 Feb.
10
Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial.手术筋膜切除术与胶原酶注射治疗复发性杜普伊特伦病的随机对照试验研究方案。
BMJ Open. 2019 Feb 25;9(2):e024424. doi: 10.1136/bmjopen-2018-024424.